Richard Brandt
Richard has been referred to as “the branding industry’s most accomplished creative director”.
During his 24 years as Landor Associates Executive Creative Director, and 30 years total in the industry, Richard has led all aspects of brand identity programs for Fortune 100 global corporations, the world’s best-known brands, and new-to-world start ups.
Passionate about all the ways branding can be a business accelerator, Richard has created programs ranging from brand identity and packaging design, naming and corporate B2B branding, as well as retail design. He has a special affinity for hospitality and particularly strong background in innovation (new brand creation).
Richard's was the creator of the "Pepsi Blue" identity, and catapulted multiple Diageo brands to worldwide success, including Smirnoff, Ketel One, Don Julio tequila, and Johnnie Walker. In recognition of his many contributions, Diageo named Richard “One of the 10 most important people in the life of the Captain Morgan brand”.
Richard as also led programs for KFC, Dean & Deluca, Embraer Jets, and Tiger Woods. He has extensive expertise across categories from luxury goods to Pharma, from OTC to food, and from cosmetics to home goods.
Always believing that the root of success is transferrable, Richard has developed an easily understood set of methodologies and best-practices designed to take consumer brands to the next level, regardless of category.
In 2015 Richard founded BrandtBrand, a strategic branding and design agency based in New York City. In 3 years, BrandtBrand has successfully created new-to-world brands, and repositioned mature brands in the health and wellness space, spirits, housewares and hospitality. Their current client roster includes The Nature’s Bounty Co., Joy Mangano, Old Elk Distilleries and Unicef, among others.
Peter McCarthy
Mr. McCarthy is now in his 7th year at Henry Schein, Inc. He is currently the Company's President, Global Animal Health Group, as well as a member of Henry Schein's Executive Management Committee.
Mr. McCarthy oversees Henry Schein's animal health business, which spans 24 countries including the United States, Australia, New Zealand, Canada, China, Malaysia, Brazil and 17 countries in Europe.
Before assuming his current position, Mr. McCarthy held key roles at Henry Schein with increasing responsibilities, including President, Henry Schein Animal Health, Europe, and President, Henry Schein Animal Health, International.
Prior to joining Henry Schein, Mr. McCarthy worked at Schering-Plough Animal Health (now Merck Animal Health), serving as Senior Director, Global Operations and General Manager, China. Mr. McCarthy also worked at Wyeth/American Cyanamid for 14 years, helping to grow the human pharmaceutical business.
Mr. McCarthy holds a degree in Applied Biology from the University of Hertfordshire in the U.K., and previously has served as a Member of the Board of the International Federation for Animal Health Europe, and the International Association Executive Animal Health Study Center, CEESA, based in Belgium. Mr. McCarthy is also a graduate and member of the Chartered Institute of Marketing (CIM), which is located in the U.K.
Pascale Jordan
Pascale Jordan got her PhD in Molecular and Cellular Biology from the Orsay University in France. She has nearly 20 years of experience in the Biotech/Pharma Industry, both Human and Animal Health. Pascale has served in a variety of roles, including Financial Analyst in Merchant Bank and Business Development Manager at Inserm Transfert, one of the leading Tech Transfer Office in France. Her last position was Business Development Director at Zoetis for the EuAfME region. She is now working as Business Development Director at Bio-Sourcing.
Kathrin Ladetzki-Baehs
Dr. Kathrin Ladetzki-Baehs joined MorphoSys > 10 years ago as a scientist. Following several years of intense laboratory work in antibody generation as a project team leader, she became an alliance manger in 2012.
Today, Kathrin (Director at MorphoSys) coordinates multiple therapeutic antibody projects in close collaboration with international external partners at MorphoSys.
Kathrin is a pharmacist and received the PhD from Ludwig Maximilians University Munich. Two dogs are beloved family members in Kathrin’s home. As one the dogs got diagnosed with canine cancer, Kathrin came up with the idea to transfer the whole expertise and knowledge of phage display, library generation and antibody generation from MorphoSys into the veterinary field. Since then she is responsible for all activities necessary to found adivo.